Anteris Technologies Global Corp. Files Registration for US Initial Public Offering

0

Anteris Technologies Global Corp. recently made an exciting announcement—they have filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering of its common stock in the U.S. This means that soon, you might have the opportunity to invest in Anteris Technologies Global Corp. by purchasing their Common Stock.

While the specific details on the amount of Common Stock to be offered and the price range have not been determined just yet, ATGC intends to list its Common Stock on the Nasdaq Global Select Market under the symbol “AVR.” Additionally, after the offering, they plan to list their CHESS Depositary Interests (CDIs) on the Australian Securities Exchange under the same symbol.

If you’re interested in learning more about this upcoming opportunity to invest in Anteris Technologies Global Corp., keep an eye out for the preliminary prospectus related to the proposed Offering. This will provide you with all the necessary information to make an informed decision about potentially participating in the offering.

It’s worth noting that while this news is exciting, it’s essential to remember that the Offering is subject to market conditions and there are no guarantees on when or if it will be completed. As always, when considering any investment opportunity, it’s crucial to do your due diligence and make informed decisions.

For those who want to know more about what ATGC does, the company was established in early 2024 to reorganize the operations of Anteris Technologies Ltd, originally an Australian public company focused on innovative medical devices. Their lead product, DurAVR®, aims to improve the lives of structural heart disease patients by providing a unique transcatheter heart valve treatment.

If you have questions or want more information, you can reach out to ATGC’s Investor Relations team at investors@anteristech.com. Stay tuned for updates as this exciting opportunity progresses!

Leave a Reply

Your email address will not be published. Required fields are marked *